ReviewMolecules (Basel, Switzerland)2021

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.

John Matsoukas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.